Table 2.
Relationships of lncRNAs with clinicopathological factors
| LncRNA | Age | Gender | Stage | T | M | N |
|---|---|---|---|---|---|---|
| AC027307.2 | -0.845 (0.398) | -0.26 (0.795) | -3.017 (0.003)* | 0.133 (0.894) | -2.431 (0.017)* | -2.347 (0.019)* |
| AC074117.1 | 1.771 (0.078) | -0.769 (0.443) | -2.915 (0.004)* | -1.104 (0.272) | -2.858 (0.006)* | -2.739 (0.007)* |
| AC103702.2 | -0.269 (0.788) | -1.984 (0.048)* | -0.127 (0.899) | -0.241 (0.810) | -1.151 (0.253) | 0.366 (0.714) |
| CYTOR | -1.688 (0.092) | 0.095 (0.925) | -1.323 (0.187) | -0.846 (0.400) | -0.599 (0.551) | -1.755 (0.080) |
| LINC02381 | 2.117 (0.036)* | 0.761 (0.447) | -1.199 (0.231) | -2.15 (0.033)* | -0.855 (0.396) | -1.601 (0.110) |
| MIR200CHG | -1.066 (0.287) | -0.011 (0.991) | 0.765 (0.445) | -0.373 (0.710) | 0.841 (0.403) | 0.451 (0.653) |
| SNHG16 | -2.178 (0.030)* | -0.738 (0.461) | 1.812 (0.071) | 1.63 (0.106) | 0.994 (0.323) | 2.311 (0.021)* |
| riskScore | 0.833 (0.406) | -0.487 (0.627) | -1.989 (0.048)* | -2.082 (0.038)* | -1.403 (0.166) | -2.041 (0.043)* |
*
indicated P < 0.05.